-

Hologic to Webcast Presentation at Upcoming Investor Conference

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the following upcoming investor conferences:

  • Bank of America 2022 Healthcare Conference on Tuesday, May 10 at 8:00 a.m. Pacific Time
  • William Blair 42nd Annual Growth Stock Conference on Tuesday, June 7 at 2:00 p.m. Central Time

The presentations will be webcast live and may be accessed through a link on the investors section of Hologic’s website at http://investors.hologic.com. The webcasts will be available for 30 days following the events.

About Hologic

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com

SOURCE: Hologic, Inc.

Contacts

Paula Izidoro
Manager, Investor Relations and Social Media
(858) 410-8904
paula.izidoro@hologic.com

Industry:

Hologic, Inc.

NASDAQ:HOLX
Release Summary
Hologic to Webcast Presentation at Upcoming Investor Conference
Release Versions
English
$Cashtags
$HOLX
Hashtags
#bofaconference
#corporatepresentation
#holx

Contacts

Paula Izidoro
Manager, Investor Relations and Social Media
(858) 410-8904
paula.izidoro@hologic.com

More News From Hologic, Inc.

New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration

MARLBOROUGH, Mass.--(BUSINESS WIRE)--New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test...

New Clinical Evidence on Hologic’s AI-Powered Mammography Solutions Will Be Unveiled at RSNA

MARLBOROUGH, Mass.--(BUSINESS WIRE)--New Clinical Evidence on Hologic’s AI-Powered Mammography Solutions Will Be Unveiled at RSNA...

Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking...
Back to Newsroom